Marygrace Taylor Author Marygrace Taylor is an award-winning freelance health and wellness writer with more than 15 years of experience covering topics including womens health, nutrition, chronic conditi...
Furthermore, the rising prevalence of obesity has significantly contributed to the growing utilization of GLP-1 analogs in the treatment of obesity, which is significantly driving the GLP-1 analogues market
Saxagliptin: Monitor renal function periodically
Several case reports indicate that the concurrent use of GLP-1RAs and dipeptidyl peptidase-IV inhibitors (DPP-4Is) might elevate the risk of developing specific cancers, such as breast, thyroid, and pancreatic cancers [124]
To view digital features for this article go to Introduction Obesity (defined as a body mass index [BMI] 30 kg/m 2 in adults [1]) is a major health concern in the USA [2] and is associated with multiple complications, including cardiovascular disease, type 2 diabetes, and osteoarthritis [3,4,5,6,7,8]